Surfactant dissolution and water solubilization in chlorine-free liquified gas propellants

Drug Development and Industrial Pharmacy

Volumn 24, Issue 10, 1998, Pages 935-945

  Blondino, Frank E ^a   Byron, Peter R ^b  

^a Baker Norton Pharmaceuticals Inc   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTAROX 31R1; BRIJ 30; BUTANE; CENTROLEX P; CHLORINE; DIETHYLENE GLYCOL MONOETHYL ETHER; DIMETHYL ETHER; DOCUSATE SODIUM; FLUORINATED HYDROCARBON; GLYCOMUL SOC; GLYCOMYL O; MACOL SA 2; MACROGOL 3000; MACROGOL 8000; MACROGOL DERIVATIVE; OLEIC ACID; PHOSPHATIDYLCHOLINE; POLIDOCANOL; POLYOXYETHYLENE STEARYL ETHER; POLYSORBATE; POLYSORBATE 20; POLYSORBATE 80; PROPANE; PROPELLANT; SORBITAN ESTER; SORBITAN OLEATE; SORBITAN SESQUIOLEATE; SORBITAN STEARATE; SORBITAN TRIOLEATE; SURFACTANT; TRICHLOROFLUOROMETHANE; UNCLASSIFIED DRUG; WATER;

ARTICLE; DRUG CONCENTRATION; DRUG SOLUBILITY; GAS; HYDROPHILICITY; LIPOPHILICITY; SCREENING; WATER CONTENT;

EID: 0031679782     PISSN: 03639045     EISSN: None     Source Type: Journal    
DOI: 10.3109/03639049809097273     Document Type: Article

References (31)

1. Montreal Protocol on Substances That Deplete the Ozone Layer, Liaison Office of the United Nations Environmental Program, New York, 1989.
2. J. J. Daly, Jr. and M. L. SanGiovanni, Replacement for CFC propellants: A technical/environmental overview, Spray Tech Marketing, 3, 34-38 (1993).
3. A. R. Ravishankara, A. A. Tumipseed, N. R. Jensen, S. Barone, M. Mills, C. J. Howard, and S. Solomon, Do hydrofluorocarbons destroy stratospheric ozone?, Science, 263, 71-75 (1994).
4. R. N. Dalby and P. R, Byron, Metered-dose inhalers containing flammable propellants: perspectives and some safety evaluation procedures, Pharm. Tech., 15, 54-66 (1991).
5. P. R. Byron, N. C. Miller, F. E. Blondino, J. E. Visich, and G. H. Ward, Some aspects of alternative propellant solvency, in Respiratory Drug Delivery IV (P. R. Byron, R. N. Dalby, and S. J. Farr, eds.), Interpharm Press, Philadelphia, PA, 1994, pp. 231-242.
6. T. S. Purewal and D. J. Greenleaf, Medicinal aerosol formulations, European Patent #0,372,777 (1990).
7. R. N. Dalby and P. R. Byron, Comparison of output particle size distributions for pressurized aerosols formulated as solutions or suspensions, Pharm. Res., 5, 36-39 (1988).
8. E. M. Phillips and P. R. Byron, Surfactant promoted crystal growth of micronized methylprednisolone in trichloromonofluoromethane, Int. J. Pharm., 110, 9-19 (1994).
9. Y. C. J. Wang and R. R. Kowal, Review of excipients and pH's for parenteral products used in the United States, J. Parent. Drug Assoc., 34, 452-462 (1980).
10. R. M. Evans, S. J. Farr, N. A. Armstrong, and S. M. Chatham, Formulation and in vitro evaluation of pressurized inhalation aerosols containing isotropic systems of lecithin and water, Pharm. Res., 8, 629-635 (1991).
11. P. R. Byron and J. S. Patton, Drug delivery via the respiratory tract, J. Aerosol Med., 7, 49-75 (1994).
12. S. Ross and J. P. Oliver, A new method for the determination of critical micelle concentrations of un-ionized association colloids in aqueous or in non-aqueous solutions, J. Phys. Chem., 63, 1671-1674 (1959).
13. S. Ross and V. H. Baldwin, Jr., The interaction between iodine and micelles of amphipathic agents in nonaqueous solutions, J. Colloid Inter. Sci., 21, 284-292 (1966).
14. P. R. Byron, Aerosol formulation, generation, and delivery using metered systems, in Respiratory Drug Delivery (P. R. Byron, ed.), CRC Press, Boca Raton, FL, 1990, pp. 167-205.
15. United States Pharmacopeia and National Formulary, USP Convention, Inc., Rockville, MD, 1995, pp. 547, 2259, 2290, 2307, 2308.
16. J. H. Fendler, Surfactants in apolar media, in Membrane Mimetic Chemistry. Characterizations and Applications of Micelles, Microemulsions, Monolayers, Bilayers, Vesicles, Host-Guest Systems, and Polyions (J. H. Fendler, ed.) John Wiley & Sons, New York, 1982, pp. 48-77.
17. P. R. Byron and F. E. Blondino, Metered dose inhaler formulations which include the ozone-friendly propellant HFC 134a and a pharmaceutically acceptable suspending, solubilizing, wetting, emulsifying or lubricating agent, U.S. Patent #5,492,688 (1996).
18. P. R. Byron and F. E. Blondino, Pharmaceutically acceptable agents for, solubilizing, wetting, emulsifying or lubricating in metered dose inhaler formulations which use HFC-227 propellant, U.S. Patent #5,508,023 (1996).
19. T. Higuchi, Solubility, in Pharmaceutical Compounding and Dispensing, (R. A. Lyman, ed.) Lippincott, Philadelphia, PA, 1949, pp. 159-190.
20. M. E. Boulden, Use of dimethyl ether for reduction of VOC content, Spray Tech. Marketing, 2, 30-36 (1992).
21. L. J. M. Bohnenn, Recent European developments in DME technology, Aerosol Age, September, 26-29 (1988).
22. A. Martin, J. Swarbrick, and A. Cammarata, States of matter and phase equilibria, in Physical Pharmacy, 3rd Ed. (A. Martin, J. Swarbrick, and A. Cammarata, eds.) Lea & Febiger, Philadelphia, PA, 1983, pp. 62-92.
23. DuPont. Blends of Dymel®22/A (40/60) azeotrope and hydrocarbons provide virtually constant pressure over wide range of component concentration, Dymel Aerosol Propellants Information, Technical Bulletin #ATB-10 Wilmington, DE.
24. R. M. Evans, D. Attwood, S. M. Chatham, and S. J. Farr, A novel strategy for the formulation of medicinal aerosols, J. Aerosol Sci., 20, 1309-1312 (1989).
25. P. L. Luisi and L. J. Magid, Solubilization of enzymes and nucleic acids in hydrocarbon micellar solutions, CRC Crit. Rev. Biochem., 20, 409-474 (1986).
26. J. Eastoe, W. K. Young, B. H. Robinson, and D. C. Steytler, Scattering studies of microemulsions in lowdensity alkanes, J. Chem. Soc. Faraday Trans., 86, 2883-2889 (1990).
27. S. Ross and I. D. Morrison, Emulsions, in Colloidal Systems and Interface (S. Ross and I. D. Morrison, eds.) John Wiley & Sons, New York, NY, 1988, pp. 267-293.
28. N. C. Miller, The effects of water in inhalation suspension aerosol formulations, in Respiratory Drug Delivery (P. R. Byron, ed.) CRC Press, Boca Raton, FL, 1990, pp. 249-257.
29. R. N. Dalby, E. M. Phillips, and P. R. Byron, Determination of drug solubility in aerosol propellants, Pharm. Res., 8, 1206-1209 (1991).
30. E. M. Phillips, P. R. Byron, and R. N. Dalby, Axial ratio measurements for early detection of crystal growth in suspension-type metered dose inhalers, Pharm. Res., 10, 454-456 (1993).
31. W. H. Soine, F. E. Blondino, and P. R. Byron, Chemical stability in pressurized inhalers formulated as solutions, J. Biopharm. Sci., 3, 41-47 (1992).